SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing renewed market attention driven by its institutional-grade post-quantum security features and its classification as a digital commodity. While the community remains divided between long-term holders optimistic about its real-world asset tokenization potential and bears focused on historic price performance, active discussions highlight a surge in trading volume and increased social dominance.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is attracting significant community attention as traders debate its potential for a breakout, with many highlighting the upcoming Layla upgrade in May 2026 as a pivotal catalyst for increased utility and quantum resistance. While bulls point to resilient price action and the network's low-fee, peer-to-peer focus, ongoing discussions remain polarized between those expecting a major decoupling from Bitcoin and critics dismissing the asset due to historical performance concerns.

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Bristol-Myers Squibb Co.

Bristol Myers Squibb is currently trending as investors focus on the company's oncology pipeline expansion and recent positive data, while also monitoring potential M&A activity within the sector. Community sentiment remains mixed as traders analyze the balance between long-term dividend stability and the upcoming challenges posed by major patent expirations.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trending due to heightened investor focus on the upcoming PDUFA decision date for RP1, with market participants debating whether the resubmission successfully addresses previous FDA concerns or if a second Complete Response Letter is likely. The community remains deeply divided, with some traders citing unusual options volume and potential short-covering as bullish indicators, while skeptics warn of significant downside risk if the company fails to secure accelerated approval.

Nucor Corp. engages in the manufacture of steel products, and ferrous and non-ferrous materials. It operates through the following segments: Steel Mills, Steel Products, and Raw Materials. The Steel Mills segment consists of producing sheet, plate, structural, and bar steel. The Steel Products segment includes steel joists and joist girders, deck, fabricated concrete reinforcing, cold finished, fasteners, metal building systems, grating, tubular, piling products businesses, and wire mesh. The Raw Materials segment consists of direct reduced iron, and ferrous and nonferrous metals. The company was founded by Ransom E. Olds in 1905 and is headquartered in Charlotte, NC.

Nucor Corp.

Nucor is trending as investors react to the anticipated formalization of 25% tariffs on global steel and aluminum imports. The community is actively discussing how these protective measures may bolster domestic manufacturing demand and pricing power, with some participants expressing caution regarding potential inflationary impacts and global trade volatility.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is currently trending as investors rotate into high-quality dividend compounders, with the community closely tracking recent FDA approvals and positive oncology pipeline data. Sentiment is further bolstered by analyst upgrades and confidence in the company's defensive strength as market participants navigate broader volatility.

U.S. Gold Corp. engages in the exploration of gold properties. It has properties in CK Gold Project, Wyoming, Challis Gold Project, Idaho, and Keystone, Nevada. The company was founded in 1967 and is headquartered in Elko, NV.

U.S. Gold Corp

U.S. Gold Corp is attracting significant attention as investors anticipate its inclusion in the Russell 2000 and 3000 indexes, which mandates institutional buying before the rebalancing date. Beyond the index momentum, the community is focused on the CK Gold Project's development status, with ongoing discussions centered on upcoming feasibility study results and the company's strategic positioning within the broader gold and copper mining sector.

Invesco DB US Dollar Index Bullish Fund - Common units of beneficial interest

Invesco DB US Dollar Index Bullish Fund

The Invesco DB US Dollar Index Bullish Fund is currently trending as markets weigh escalating trade tensions and geopolitical uncertainty against conflicting labor data and shifting Federal Reserve rate expectations. Investors are actively debating the dollar's role as a safe-haven asset amidst potential policy realignments, currency intervention risks, and ongoing debates over U.S. fiscal deficits and de-dollarization.

Maul Coin

Maul Coin is generating buzz as a community-driven project aiming to replicate the massive growth of previous viral memecoins through active social media raiding and a transparent developer-led approach. While the community is currently focused on overcoming technical hurdles like securing official charts and listings, members are heavily incentivized by the potential for 1000x gains and a movement-based ethos that rejects typical 'pump and dump' behavior.

iShares Trust - iShares Russell 2000 Value ETF

iShares Russell 2000 Value ETF

The iShares Russell 2000 Value ETF (IWN) is trending as investors monitor ongoing Federal Reserve policy debates and geopolitical volatility, with many community members focusing on the index as a bellwether for small-cap performance. Traders are actively discussing the potential for a rotation into value-oriented small-cap equities, frequently using IWN and the Russell 2000 to gauge market breadth and position against broader index trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/">WealthyVC.com</a> scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in sectors actively drawing capital. This targeted approach, combined with real-time news surveillance, helps us uncover stocks poised for powerful multi-day or multi-month moves—often long before Wall Street analysts catch on.Here’s a list of today’s most important names.&nbsp;1. ReposiTrak (NYSE: TRAK)Background: ReposiTrak operates the world’s largest food traceability and regulatory compliance network, providing inventory management solutions to enhance food safety and regulatory compliance. The ReposiTrak Traceability Network (RTN) connects over 4,000 suppliers and helps ensure proactive adherence to FDA guidelines.The News: ReposiTrak&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/repositrak-welcomes-50-dairy-egg-120000689.html">recently welcomed</a> 50 new dairy and egg suppliers to its RTN. These suppliers will utilize the platform to exchange FDA-mandated Key Data Elements ahead of the January 2026 regulatory deadline. Among the new members are a fourth-generation, family-owned egg producer, a global dairy cooperative, and a pasture-raised farming brand.What it Means: By expanding its network with these suppliers, ReposiTrak bolsters its position as a leader in food traceability. The additions also enhance the network’s value for retailers, allowing for efficient, regulation-compliant data exchange. With food safety regulations tightening, ReposiTrak’s hardware-free approach is attracting widespread industry adoption.Stock Reaction: TRAK stock saw an increase in trading volume whilst eking out a small gain for the day (1.3%), with investors noting the company’s strengthened market position in traceability and compliance solutions.Social Sweep: Traders on&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/search?q=%24TRAK&amp;src=typed_query">X.com</a> and&nbsp;<a href="https://stocktwits.com/symbol/TRAK">StockTwits</a> are trumpeting the fact that TRAK is the only food traceability solution in a world where there’s seemingly a new story about food safety issues every day.&nbsp;2. BioStem Technologies (OTC: BSEM)Background: BioStem Technologies specializes in regenerative medicine, focusing on placental-derived biologics. Through its proprietary BioREtain® technology, the company develops wound care products, such as AmnioWrap2®, to treat conditions like diabetic foot ulcers.The News: BioStem reported&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/biostem-technologies-reports-record-third-122900564.html">record Q3 revenue</a> of $82.6 million, marking its third consecutive quarter of growth. The&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/biostem-technologies-initiates-nationwide-launch-110000160.html">launch</a> of Vendaje AC® in partnership with Venture Medical and broad Medicare reimbursement coverage boosted earnings. Additionally, BioStem filed for a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/biostem-technologies-inc-files-form-110000681.html">Nasdaq uplisting</a> and initiated a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/biostem-technologies-initiates-br-ac-110000608.html">clinical trial</a> for diabetic foot ulcer treatment.What it Means: BioStem’s consistent revenue growth highlights strong market acceptance for its innovative wound care products. The Medicare coverage and new clinical trials further enhance its potential market reach, positioning BioStem as a key player in regenerative therapies. The Nasdaq uplisting could bring additional visibility and investment.Stock Reaction: BSEM shares experienced a modest rise, as investors responded positively to the earnings growth and the prospect of a national listing.Social Sweep: Investors on&nbsp;<a href="https://stocktwits.com/symbol/BSEM">StockTwits</a> are lauding the fact that BSEM will attract many more institutional investors when they up-list to a national exchange. This is at a time when they’re growing very fast which could bode well for the stock.&nbsp;3. Mogo (NASDAQ: MOGO)Background: Mogo is a financial technology company that offers digital wealth and payment services. Its subsidiary, Carta Worldwide, provides global digital payment processing and is increasingly gaining traction in the European market.The News: Mogo&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/mogo-digital-payments-subsidiary-carta-131700962.html">announced</a> that Carta Worldwide processed $3 billion in payment volume in Q3, a 23% increase year-over-year. This achievement marks a new record for Carta and reflects the success of its partnerships with large European clients, positioning it as a robust player in the international payments space.What it Means: The increased transaction volume signals growing demand for Carta’s payment solutions and reflects Mogo’s solid foothold in the global payments market. This growth could further fuel Mogo’s revenue streams, with management expressing confidence in Carta’s trajectory toward a $12 billion annual run rate.Stock Reaction: MOGO stock saw an 8.2% drop, most likely profit-taking after a monster multi-day run after beating on&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/mogo-reports-results-q3-2024-131800495.html">earnings</a> last week. This morning’s news seemed to have fallen on deaf ears.Social Sweep: Investors on&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/search?q=%24MOGO&amp;src=typed_query&amp;f=live">X.com</a> and&nbsp;<a href="https://stocktwits.com/symbol/MOGO">StockTwits</a> seem to be reaching pessimistic/ bearish exhaustion with this former high-flyer. With the majority of posts being bearish, it appears investors have had enough and the name has fallen out of favour. This could be the ultimate contrarian signal or a value trap—time will tell.&nbsp;4. Birchtech (OTC: BCHT)Background: Birchtech, formerly known as Midwest Energy Emissions Corp., is an environmental technology company focused on sustainable solutions for water and air purification. Its operations include mercury emissions capture and PFAS water treatment technologies.The News: Birchtech&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/birchtech-announces-move-onto-toronto-130700750.html">began trading</a> on the Toronto Stock Exchange today, transitioning from the TSX Venture Exchange. This listing boosts the company’s visibility among institutional and retail investors, particularly those focused on environmental technology. CEO Richard MacPherson noted that Birchtech’s recent lab center launch for PFAS water treatment further underscores its innovation in environmental tech.What it Means: The TSX listing marks an important milestone, providing Birchtech with increased visibility and access to larger capital pools. With PFAS treatment becoming a growing concern globally, Birchtech’s technologies could position it to capitalize on the demand for sustainable water purification.Stock Reaction: BCHT shares rose by 2.86% following the announcement, with investors reacting favorably to the enhanced market exposure and potential growth in water treatment solutions.Social Sweep: Investors on social media are lauding the TSX up-listing expecting it to drive additional investment. Others are cautiously optimistic citing the fact that the fundamentals will have to improve for the increased exposure to matter.&nbsp;5. Momentus (NASDAQ: MNTS)Background: Momentus is a commercial space company providing satellite buses and in-space services. Its Vigoride platform is designed for defense, commercial, and government customers, supporting a range of low-Earth orbit missions.The News: Momentus&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/momentus-receives-halo-prototype-order-130000889.html">was awarded</a> a prototype order contract under the Defense Department’s HALO program. This contract, part of a broader initiative to develop space technologies for national security, allows Momentus to participate in rapid prototyping missions for the U.S. Space Development Agency.What it Means: This contract positions Momentus as a key player in defense-focused space infrastructure. The HALO program’s focus on quick-turnaround prototyping could pave the way for future collaborations and solidify Momentus’s role in government contracts.Stock Reaction: MNTS shares fell 7%, on lower than average trading volume as investors shrugged off the company’s purchase order news, or more likely the hangover from the&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/momentus-receives-nasdaq-notice-delisting-210000504.html">Nasdaq delisting</a> notice from last month.Social Sweep: MNTS is currently registering bearish sentiment on&nbsp;<a href="https://stocktwits.com/symbol/MNTS">StockTwits</a>, one notch up from very bearish and message volume has been increasing on the platform. Most on the platform are bullish on the prospect of a Trump administration Space Force which could drive revenue.&nbsp;6. ON24 (NYSE: ONTF)Background: ON24 is a leading engagement platform for B2B sales and marketing. Its solutions help companies conduct virtual events and webinars, capturing insights that enhance audience engagement and drive business results.The News: ON24 was recognized as a top engagement platform in the&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/on24-ranked-top-engagement-platform-130000747.html">G2 Fall 2024 Report</a>, reflecting high customer satisfaction and strong market presence. The company’s use of AI-driven insights has helped maintain its position as a leader in virtual engagement solutions, particularly for enterprises focused on digital-first strategies.What it Means: ON24’s high placement in G2 rankings highlights its reputation in the virtual engagement space. As more companies adopt digital engagement solutions, ON24’s standing as a trusted platform is likely to attract further enterprise clients, expanding its revenue potential.Stock Reaction: ONTF shares rose by 0.15% in response to the G2 ranking news, as investors view the positive reception as an indicator of the company’s growth potential.Social Sweep: Most traders on&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/search?q=%24ONTF&amp;src=typed_query">X.com</a> are bullish on the chart pattern citing the fact that the stock looks like it’s ready to break out. Others are bearish because of declining sales.&nbsp;7. Richardson Electronics (NASDAQ: RELL)Background: Richardson Electronics is a global provider of engineered solutions, focusing on power technologies and custom display solutions. Its distribution network supports key industries, including renewable energy, healthcare, and semiconductors.The News: Richardson Electronics expanded its&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/navitas-richardson-electronics-ltd-expand-143000799.html">distribution partnership</a> to cover Europe, the Middle East, and Africa (EMEA), offering broader access to its cutting-edge power technologies. This extension supports Richardson’s strategy to capture demand in emerging renewable energy and semiconductor markets across the EMEA region.What it Means: This partnership positions Richardson Electronics to leverage the rising demand for power solutions, especially in renewables and high-performance technologies. The EMEA expansion reflects the company’s commitment to growth and positions it as a supplier of choice in the energy and industrial sectors.Stock Reaction: RELL shares experienced a modest increase today, but have rallied 26% over the past 90 days as the extended distribution deal highlights the company’s international growth ambitions.Social Sweep: Investors on&nbsp;<a href="https://stocktwits.com/symbol/RELL">StockTwits</a> are overall bearish on the stock contrary to the massive run it had. Most of the minority who are bullish are citing insiders buying stock as the reason.&nbsp;<hr>&nbsp;Also Read:&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/tech/all-systems-go-ast-spacemobile-asts-stock-throttles-up-en-route-to-the-stars/">The 2024 Space Race is All Systems Go—As Space Stocks Throttle Up, Our Top Pick Has Already Rocketed 588% Higher in Just Three Months</a>Be The First to Know:&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://wealthyvc.com/newsletter-sign-up/">Our email list eats first! Get exclusive alerts on explosive stock picks like AST SpaceMobile (NASDAQ: ASTS) which shot up +533% after our profile or Fangdd Network (NASDAQ: DUO) which skyrocketed +200% after our alert. Get our email signals based on our proprietary 5-indicator system before any of our other platforms by clicking here.</a>&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/WealthyVC">Follow us on Twitter</a> | <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.instagram.com/wealthyventurecapital/">Follow us on Instagram</a> | <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/TheWealthyVentureCapitalist/?locale=zh_CN">Follow us on Facebook</a> | <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.facebook.com/groups/WealthyVC">Join the Discussion in the WVC Facebook Investor Group</a>Have a Stock Tip or New&nbsp; Story Suggestion? Email us at&nbsp;Invest@WealthyVC.comDisclaimer: Wealthy VC does not hold a position in any of the stocks, ETFs or cryptocurrencies mentioned in this article.This article was written by an independent contributor and does not reflect the views of Stocktwits. It has not been edited for content. The information provided here is intended solely for informational and educational purposes, and should not be interpreted as investment advice. Stocktwits does not endorse the purchase or sale of any security nor does it make any claims about the financial status of any company.

Small and Micro-Cap Movers: Your Daily Digest of High-Impact News From High-Growth Companies Rising in Popularity

Equity

The only curated source of news from smaller, under-the-radar stocks in the hottest sectors ready to make a move, and the analysis and rumors from social media driving the price action.

BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments 

BioStem appears exceptionally well-positioned to capitalize on and maximize value from products that target specialized indications in the regenerative medicine and MedTech sector.  

BioStem Technologies Inc In A Race To The Top With Innovative Wound-Care Treatments 

public companies

Innovation is the lifeblood of the MedTech sector. Literally. Discoveries made are more than value drivers for the companies behind them; they can be life savers to millions needing better and more effective healthcare solutions.

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.

BioStem Technologies Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

BSEM
Biostem Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BSEM News

BSEMBiostem Technologies Inc